OMIC
Singular Genomics Systems, Inc. announced the closing of its acquisition by an affiliate of Deerfield Management Company, L.P. Pursuant to the transaction, Josh Stahl has been appointed to lead Singular Genomics as Chief Executive Officer and will join the company's Board of Directors. Jason Myers will also join the Board. Drew Spaventa, co-founder of Singular Genomics and the company's previous Chief Executive Officer and Chairman, will continue to serve on the Board and assume an additional role as special advisor to the CEO.